Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit

N. Grössmann, J.C. Del Paggio, S. Wolf, R. Sullivan, C.M. Booth, K. Rosian, R. Emprechtinger, C. Wild
2017 European Journal of Cancer  
doi:10.1016/j.ejca.2017.05.029 pmid:28648700 fatcat:diaapitxbffktgntenewhkezyq